India’s top health research body is reviewing its treatment guidelines for Covid-19 and may drop hydroxychloroquine (HCQ) from the protocol due to increasing doubt over its effectiveness, people in the know told ET. Read More
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.